Osom Ultra hCG Combo Test- IVD immunoassay for the qualitative detection of human chorionic gonadotropin (hCG) in serum or urine for the early confirmation of pregnancy. Model/Catalog Number: 1004
Published November 6, 2024 · Recall initiated: August 23, 2024
Summary
FDA records medical device Class II recall Z-0259-2025, published November 6, 2024 and initiated August 23, 2024. Recalling firm: Princeton Biomeditech Corp; Status: Ongoing; Reported quantity: 1,860 kits (50,220 test devices); Lot: UDI-DI: 00742860100208 Lot Number: 563L13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
This recall was initiated due to customer complaints of false negative of hCG test results when running patient urine samples. Use of the above listed product lot may result in false negative results. An end user reported that the OSOM Ultra hCG Combo Test, lot 563L13, produced false negative test results from 2 patient urine samples as confirmed by quantitative hCG and ultrasound. During further root cause testing and investigation, an additional 6 devices were found to produce false negative test results from hCG positive samples.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Princeton Biomeditech Corp
- Distributor
- US Distribution to MO only.
- Lot
- UDI-DI: 00742860100208 Lot Number: 563L13
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDA17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro diagnosticNovember 6, 2024
- FDAProduct Name: Insight Base Flex - 8, Ref 608-3TX; The device consists of a sterile Snap that includesNovember 6, 2024
- FDAChameleon PTA Balloon Catheter with Injection Port 5mm x 40mm x 75cm (CFN CH05-40-75US), 6mm x 40mm x 75cmNovember 6, 2024
- FDAPoly stat Flu A & B Test Manufactured for Polymedco 510 Furnace Dock Road Cortlandt Manor, NY 10567 TelSeptember 12, 2012
- FDAStatus Flu A + B Test Manufactured by Princeton Bio Meditech Corporation Monmouth Junction, NJ 08852 USA. TheSeptember 12, 2012
- FDAOrasure QuickFlu Rapid A+B Test Manufactured for OraSure Technologies, Inc Bethlehem, PA 18015 USA. TheSeptember 12, 2012
Questions about this recall
Was Osom Ultra hCG Combo Test- IVD immunoassay for the qualitative detection of human chorionic gonadotropin (hCG) in serum or urine for the early confirmation of pregnancy. Model/Catalog Number: 1004 recalled?
Yes. FDA published recall Z-0259-2025 on November 6, 2024. Reported hazard: This recall was initiated due to customer complaints of false negative of hCG test results when running patient urine samples. Use of the above listed product lot may result in false negative results. An end user reported that the OSOM Ultra hCG Combo Test, lot 563L13, produced false negative test results from 2 patient urine samples as confirmed by quantitative hCG and ultrasound. During further root cause testing and investigation, an additional 6 devices were found to produce false negative test results from hCG positive samples.
What should I do if I have this product?
Voluntary: Firm initiated · Letter